Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve, Inc. is a Canada-based healthcare technology company. The Company has two business units: Medivolve Pharmacy Division (MPD) and Collection Sites Diagnostics (CSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine, and psychiatry to patients in Southern California. CSD’s software platform, Electronic Health Records app (EHR), is focused on supporting clinical staff, is a series of assets and functionalities that enhance the customer experience and provide an end-to-end lab solution. The Company, through its subsidiaries, Medivolve Pharmacy Inc., and Kedy Ying Jao D.O., a medical corporation, operate a distributed network of two retail patient-care locations in California, United States. The Company has served hundreds of thousands of patients across the United States and facilitated more than 1,533,000 clinical tests.


OTCPK:MEDVF - Post by User

Comment by knowsbeston Mar 01, 2021 3:21pm
180 Views
Post# 32687434

RE:February covid-19 testing numbers should be out soon

RE:February covid-19 testing numbers should be out soonPIVOT..PIVOT..that is how you distract ..but not for long they are coming for you and your fart catchers ..but thats easy they are going after the real toxic sh.t 

"If those revenue numbers are similar or most likely better than January which was $11.6 million. Then just 2 months alone can justify the current share price."
Unvelivable all the PUMP for the last 4-5 months just to justify the current price .For all investors new and old is that what you were hopping for ??? Read all the calculations and BS from the past and you will know what I mean . It is sad but expected from a scammer .slimer and manipulator .


"Let alone collection sites revenue for another 10 months"..all speculation ,manipulation and BS .

Very possible and most probable the company will not be around that long .

Its your money you make the choice you live with it . Just look at the SP





<< Previous
Bullboard Posts
Next >>